These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

340 related items for PubMed ID: 12679647

  • 21. Vincristine induced peripheral neuropathy potentiated by voriconazole in a patient with previously undiagnosed CMT1X.
    Porter CC, Carver AE, Albano EA.
    Pediatr Blood Cancer; 2009 Feb; 52(2):298-300. PubMed ID: 18837430
    [Abstract] [Full Text] [Related]

  • 22. Incidence of vincristine induced neurotoxicity in children with acute lymphoblastic leukemia and its correlation with nutritional deficiencies.
    Dudeja S, Gupta S, Sharma S, Jain A, Sharma S, Jain P, Aneja S, Chandra J.
    Pediatr Hematol Oncol; 2019 Sep; 36(6):344-351. PubMed ID: 31514565
    [Abstract] [Full Text] [Related]

  • 23. Vincristine-induced paralytic ileus during induction therapy of treatment protocols for acute lymphoblastic leukemia in adult patients.
    Yasu T, Ohno N, Kawamata T, Kurokawa Y.
    Int J Clin Pharmacol Ther; 2016 Jun; 54(6):471-3. PubMed ID: 27087157
    [Abstract] [Full Text] [Related]

  • 24. Gait characteristics of children and youth with chemotherapy induced peripheral neuropathy following treatment for acute lymphoblastic leukemia.
    Wright MJ, Twose DM, Gorter JW.
    Gait Posture; 2017 Oct; 58():139-145. PubMed ID: 28779719
    [Abstract] [Full Text] [Related]

  • 25. Measuring vincristine-induced peripheral neuropathy in children with acute lymphoblastic leukemia.
    Lavoie Smith EM, Li L, Hutchinson RJ, Ho R, Burnette WB, Wells E, Bridges C, Renbarger J.
    Cancer Nurs; 2013 Oct; 36(5):E49-60. PubMed ID: 23842524
    [Abstract] [Full Text] [Related]

  • 26. Genetic epidemiology of Charcot-Marie-Tooth disease.
    Braathen GJ.
    Acta Neurol Scand Suppl; 2012 Oct; (193):iv-22. PubMed ID: 23106488
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Prospective assessment of vincristine-induced peripheral neuropathy in paediatric acute lymphoblastic leukemia.
    Li T, Kandula T, Cohn RJ, Kiernan MC, Park SB, Farrar MA.
    Clin Neurophysiol; 2023 Oct; 154():157-168. PubMed ID: 37633123
    [Abstract] [Full Text] [Related]

  • 32. Heterozygosity for CMT Type 4 Predicts a Severe Vincristine-induced Polyneuropathy Phenotype: A Case Report and Review of Literature.
    Sy A, Cheng J, Cooper R, Mueller L.
    J Pediatr Hematol Oncol; 2019 Jan; 41(1):e41-e43. PubMed ID: 29877907
    [Abstract] [Full Text] [Related]

  • 33. Adult medulloblastoma: multiagent chemotherapy.
    Greenberg HS, Chamberlain MC, Glantz MJ, Wang S.
    Neuro Oncol; 2001 Jan; 3(1):29-34. PubMed ID: 11305414
    [Abstract] [Full Text] [Related]

  • 34. Lack of association of the CEP72 rs924607 TT genotype with vincristine-related peripheral neuropathy during the early phase of pediatric acute lymphoblastic leukemia treatment in a Spanish population.
    Gutierrez-Camino A, Martin-Guerrero I, Lopez-Lopez E, Echebarria-Barona A, Zabalza I, Ruiz I, Guerra-Merino I, Garcia-Orad A.
    Pharmacogenet Genomics; 2016 Feb; 26(2):100-2. PubMed ID: 26618658
    [Abstract] [Full Text] [Related]

  • 35. Severe vincristine neurotoxicity in a patient with Charcot-Marie-Tooth disease.
    Dickerhoff R, Lindner W, Scheiber W.
    Pediatr Hematol Oncol; 1988 Feb; 5(1):61-4. PubMed ID: 3152952
    [No Abstract] [Full Text] [Related]

  • 36. Neuromuscular hip dysplasia in Charcot-Marie-Tooth disease type 1A.
    Bamford NS, White KK, Robinett SA, Otto RK, Gospe SM.
    Dev Med Child Neurol; 2009 May; 51(5):408-11. PubMed ID: 19388151
    [Abstract] [Full Text] [Related]

  • 37. Mild axonal neuropathy of children during treatment for acute lymphoblastic leukaemia.
    Reinders-Messelink HA, Van Weerden TW, Fock JM, Gidding CE, Vingerhoets HM, Schoemaker MM, Göeken LN, Bökkerink JP, Kamps WA.
    Eur J Paediatr Neurol; 2000 May; 4(5):225-33. PubMed ID: 11030069
    [Abstract] [Full Text] [Related]

  • 38. Uneventful administration of vincristine in Charcot-Marie-Tooth disease type 1X.
    Ajitsaria R, Reilly M, Anderson J.
    Pediatr Blood Cancer; 2008 Apr; 50(4):874-6. PubMed ID: 17514737
    [Abstract] [Full Text] [Related]

  • 39. Fluoroquinolone prophylaxis does not increase risk of neuropathy in children with acute lymphoblastic leukemia.
    Karol SE, Sun Y, Tang L, Pui CH, Ferrolino J, Allison KJ, Cross SJ, Evans WE, Crews KR, Jeha S, Wolf J.
    Cancer Med; 2020 Sep; 9(18):6550-6555. PubMed ID: 32710497
    [Abstract] [Full Text] [Related]

  • 40. Early recognition of hereditary motor and sensory neuropathy type 1 can avoid life-threatening vincristine neurotoxicity.
    Naumann R, Mohm J, Reuner U, Kroschinsky F, Rautenstrauss B, Ehninger G.
    Br J Haematol; 2001 Nov; 115(2):323-5. PubMed ID: 11703329
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.